CNS Pharmaceuticals, Inc. , a clinical pharmaceutical company, engages in the development of anti-cancer drug candidates for the treatment of brain and central nervous system tumors.
Cns Pharmaceuticals stock last closed at $9.54, up 3.14% from the previous day, and has decreased 87.18% in one year. It has underperformed other stocks in the Biotechnology industry by 0.61 percentage points. Cns Pharmaceuticals stock is currently +93.51% from its 52-week low of $4.93, and -95.7% from its 52-week high of $221.94.
As of Oct 14, 2025, there are 574,580 CNSP shares outstanding. The market cap of CNSP is $5.48M. In the last 24 hours, 29,800 CNSP shares were traded.
You will need a brokerage account to access the NASDAQ market and buy CNSP stock.
Based on our analysis, eToro is the best online stock brokerage. eToro gives you:
Get $10 towards your share purchase by signing up for an account with eToro today. This offer is only for US users.
Open eToro AccountNow that you've selected the best brokerage, you need to fill out some personal details so you are able to buy CNSP today.
Now that you've filled out your info on one of the most highly reviewed stock apps, you can securely and quickly fund your account:
Watch the tutorial below to see the process of depositing money into your new investment account.
After you have chosen the best place to buy Cns Pharmaceuticals stock, it's crucial to analyze their stock prior to investing, so you can wrap your head around the risk and opportunity.
WallStreetZen was built to help average investors do better fundamental analysis.
You can see all of the due diligence checks on CNSP's stock page.
Investors use many financial metrics, analyses, models, and charts to gauge CNSP's intrinsic value.
Using relative valuations methods:
You can access more valuation analysis on CNSP's stock here.
Out of 1 Wall Street analysts who give forecasts on CNSP, the consensus analyst rating on Cns Pharmaceuticals is a Strong Buy
Please keep in mind that analyst forecasts are not stock recommendations, nor are they investment advice.
You can dig deeper into what analysts are projecting on the Cns Pharmaceuticals stock forecast page.
Over the past 12 months, insiders at CNSP have not bought or sold any shares.
Learn more about who owns CNSP stock here.
No, Cns Pharmaceuticals doesn't provide an income stream by paying out dividends.
One of the primary reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to find out what other traders have to say.
There are two main options:
Press the Open Trade button and eToro will place your order.
If you require more info about buying stocks on eToro, watch the how to video below:
Now that you own some shares in CNSP, you'll want to keep up with your stock purchase.
Put CNSP on a watchlist to get alerted to the latest events about your CNSP stock.
To reiterate, here are the 6 steps to buy Cns Pharmaceuticals stock:
If you require a place to buy stocks, eToro is our recommended option.
Get Started with eToro TodayIf you would like to get notifications regarding your new investment in Cns Pharmaceuticals, create a watchlist on WallStreetZen today.